Home » Topics » BioWorld Science

BioWorld Science
RSS

REVTx-99 demonstrates in vitro antiviral activity against SARS-CoV-2

Jan. 12, 2022

Methamphetamine harnessed for good in BBB transport

Jan. 12, 2022

CD6-ALCAM pathway is a therapeutic target in SLE

Jan. 12, 2022

Wigen Biomedicine Technology presents new CDK inhibitors

Jan. 12, 2022

Betta Pharmaceuticals synthesizes new HIF-2alpha inhibitors

Jan. 12, 2022

Abbisko Therapeutics identifies new PD-1/PD-L1 interaction inhibitors

Jan. 12, 2022

Anaxis Pharma patents MLKL inhibitors

Jan. 12, 2022

Amgen and Arrakis collaborate to discover and develop targeted RNA degrader therapeutics

Jan. 12, 2022

Leo Pharma discloses IL-17 modulators

Jan. 12, 2022

TuA-derived hPep elicits long-term anticancer immunity in mice

Jan. 12, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...